ADVANCED CYTOMETRY INSTRUMENTATION SYSTEMS LLC
Medtech · Private
Smart Photodynamic Therapy (S-PDT) platform for targeted treatment of acne via selective sebocyte destruction
acis-us.com →- Grants
- $1.3M
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $10K
- 1 award · Health and Human S
- #631 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel single cell assay for quantitative analysis of cell heterogeneity by noninvasive probing of molecular composition of specific organelles in individual cells | $148,067 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel single cell assay for quantitative analysis of cell heterogeneity by noninvasive probing of molecular composition of specific organelles in individual cells | $1,193,945 | |
| Federal contract | Department of Health and Human Services · Lab Supplies | $9,980 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 628 | DuraStat LLC | $11K | $6.8M |
| 629 | Stimlabs LLC | $10K | $10M |
| 630 | CREOSALUS INC. | $10K | — |
| 631 | ADVANCED CYTOMETRY INSTRUMENTATION SYSTEMS LLC | $10K | — |
| 632 | InCellDx, Inc. | $10K | $9.5M |
| 633 | Insightra Medical, Inc. | $9K | $20M |
| 634 | OSMIC ENTERPRISES, INC. | $9K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.